Asosiy kontentga oʻtish
AkademScholar
Muassasalar

Research Institute Hospital 12 de Octubre

Nom variantlari: Instituto de Investigación Hospital 12 de Octubre · i+12

Davlat:
ES
ROR:
https://ror.org/002x1sg85
4
h-indeks
60
Iqtiboslar
20
Asarlar
27
Mualliflar
Vaqt boʻyicha

Vaqt boʻyicha tahlil

Iqtibos sharhi

Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)

  • Nashrlar
  • Iqtiboslar
013450510152020172018201920202021202220232024202520262017: Nashrlar 1, Iqtiboslar 02018: Nashrlar 2, Iqtiboslar 02019: Nashrlar 2, Iqtiboslar 22020: Nashrlar 2, Iqtiboslar 52021: Nashrlar 2, Iqtiboslar 02022: Nashrlar 1, Iqtiboslar 102023: Nashrlar 0, Iqtiboslar 162024: Nashrlar 3, Iqtiboslar 192025: Nashrlar 2, Iqtiboslar 42026: Nashrlar 1, Iqtiboslar 4

Iqtibos tarixi

0510152020172018201920202021202220232024202520262017: Iqtiboslar 02018: Iqtiboslar 02019: Iqtiboslar 22020: Iqtiboslar 52021: Iqtiboslar 02022: Iqtiboslar 102023: Iqtiboslar 162024: Iqtiboslar 192025: Iqtiboslar 42026: Iqtiboslar 4

Nashr tarixi

0134520172018201920202021202220232024202520262017: Nashrlar 12018: Nashrlar 22019: Nashrlar 22020: Nashrlar 22021: Nashrlar 22022: Nashrlar 12023: Nashrlar 02024: Nashrlar 32025: Nashrlar 22026: Nashrlar 1

h-indeks evolyutsiyasi

Yillar boʻyicha jamlangan h-indeks

0134520172018201920202021202220232024202520262017: h-indeks 02018: h-indeks 02019: h-indeks 12020: h-indeks 22021: h-indeks 22022: h-indeks 22023: h-indeks 32024: h-indeks 42025: h-indeks 42026: h-indeks 4

Eng koʻp iqtibos qilingan asarlar

  1. Diversity of kidney care referral pathways in national child health systems of 48 European countries20241 iqtibos
  2. Deep learning-based postoperative glioblastoma segmentation and extent of resection evaluation: Development, external validation, and model comparison20240 iqtibos
  3. Achievements, priorities and strategies in pediatric nephrology in Europe: need for unifying approaches or acceptance of differences?20240 iqtibos
  4. Diversity of kidney care referral pathways in national child health systems of 48 European countries20250 iqtibos
  5. Achievements, priorities and strategies in pediatric nephrology in Europe: need for unifying approaches or acceptance of differences?20250 iqtibos
  6. Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis20260 iqtibos